Wednesday, August 28, 2013

Allied granted CE mark for lead regenerative product CardioCel®

Allied Healthcare Group have announced that CardioCel® has received CE mark approval, allowing the company to launch and market the product in Europe. The CE mark for CardioCel® allows for the repair and reconstruction of heart defects including treating congenital heart disease and repairing heart valves in both children and adults...

No comments:

Post a Comment